Pieris
Acquired- Headquarters
- Hallbergmoos
- Employees
- 51–200
- Business Model
- B2B
- Website
- pieris.com
About
Pieris Pharmaceuticals is a clinical-stage biopharmaceutical company pioneering Anticalin proteins - a novel class of therapeutic biologics derived from human lipocalins. The company focuses on bispecific fusion proteins targeting oncology and respiratory diseases.
Summary
Pieris is a Biotech company based in Hallbergmoos, Germany. Investors include Bayern Kapital and Forbion Capital Partners.
Funding History
Dec 2024
Sign up to see all 2 rounds
IPO through Merger — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/pieris"><img src="https://indexed.vc/api/badge/company/pieris" alt="Pieris on Indexed.vc" width="260" height="76" /></a>